How Food Choices Shape Memory, Cognition & Cravings | Dr. Scott Kanoski

Glp-1: Natural Hormone and Pharmaceutical Enhancement

Glp-1: An Incretin Hormone and Appetite Suppressant

Glucagon-like peptide-1 (GLP-1) is a natural incretin hormone secreted from the distal intestines, mostly during and after food ingestion, with some baseline secretion before a meal begins. This hormone not only enters the bloodstream from the gut but is also produced centrally in the brain's nucleus tractus solitarius, allowing extensive signaling throughout the brain. Both peripheral and central GLP-1 systems independently contribute to hunger suppression.

Pharmaceutical Glp-1 Receptor Agonists, Initially For Diabetes, Raise Glp-1 Levels a Thousandfold, now Noted For Weight Loss

GLP-1–based drugs were initially developed for diabetes, aiding by stimulating [restricted term] secretion in response to elevated blood glucose. These pharmaceuticals, such as Ozempic and Wegovy, now are more widely recognized for their appetite- and weight-suppressing effects. Drug-induced GLP-1 levels are super-physiological, increasing up to a thousandfold compared to natural bodily secretion.

Appetite Suppression Through Vagal and Peripheral Signaling

Glp-1 Reduces Food Intake Via Paracrine Mechanisms On Vagus Nerve Terminals, Sending Satiation Signals to the Brain

GLP-1 released from gut L cells acts locally (paracrine mechanism) on GLP-1 receptors located on the terminals of the vagus nerve that innervate the gastrointestinal tract. This signaling is a crucial part of producing the sensation of fullness (satiation) during meals. Signals travel from the vagus nerve to the brainstem, informing it that enough food has been consumed. GLP-1 is therefore central in orchestrating meal termination alongside other gut-derived signals.

Vagus Nerve Essential for Glp-1 Appetite Suppression; Lesioning Negates Effects

Experimental data show that the vagus nerve is essential for the appetite-suppressing effects of endogenous GLP-1. When the sensory vagus nerve is selectively lesioned, peripheral GLP-1 injections do not reduce food intake. Animals with reduced GLP-1 receptor expression on the vagus nerve also eat larger meals, demonstrating the nerve’s critical role.

Potential Cognitive and Non-weight Loss Benefits

Glp-1 Receptors in Brain Regions Beyond Appetite Control, Including the Hippocampus and Mesolimbic Circuits, Suggest Potential for Memory, Dementia, and Substance Abuse Disorders

GLP-1 receptors are widespread throughout the brain, found in regions involved not only in food intake regulation but also in reward (mesolimbic circuits such as the VTA and nucleus accumbens) and cognition (hippocampus). This distribution raises the possibility of using GLP-1 receptor agonists to address disorders like substance abuse, memory impairment, and dementia. Preliminary preclinical data support these applications, and clinical research is ongoing.

Glp-1 Drugs and Blood-Brain Barrier: Early Generations Penetrate More Easily Than Newer Versions; Ongoing Research With Radioactive Labeling

The extent to which GLP-1 drugs penetrate the brain remains debated. Early-generation GLP-1 drugs appear to cross the blood-brain barrier more readily in animal studies, with drug action demonstrated in circumventricular organs lacking a strong blood-brain barrier. Newer agents (such as Ozempic and Wegovy) may take longer or may not penetrate as efficiently. Definitive localization is complicated by technical challenges in tracking the drugs; studies using radio-labeled peptides (e.g., with carbon-14), which can more conclusively confirm distribution, are ongoing.

Side Effects, Long-Term Efficacy, and Discontinuation Patterns

Glp-1 Drugs Often Stopped Due to Nausea, Costs, or Muscle Loss

GLP-1 drugs frequently cause side effects—most commonly nausea and vomiting—which lead many patients to discontinue use. Cost is another major barrier to sustained treatment. Weight loss from GLP-1 agonists includes both fat and lean mass (e.g., muscle), adding further cause for discontinuation, especially among elderly users. Most patients do not stay on these drugs for more than two years.

Lack of Long-Term Clinical Trial Data on Glp-1 Use in Lean, Non-obese Populations Leaves Potential Risks and Benefits Outside Clinical Para ...

Extensive research highlights the profound effects of diet, especially during development, on brain health, memory, and long-term risk for neurodegenerative diseases. Both rodent and human studies reveal that sugar, processed foods, and imbalanced macronutrient intake can negatively influence hippocampal-dependent memory, often through mechanisms involving the gut microbiome, metabolic dysfunction, and the chemical byproducts of food processing.

Sugar Consumption During Development Produces Persistent Memory Deficits

Ad Libitum Sugar Access in Youth Impairs Adult Hippocampal-Dependent Memory

Scott Kanoski’s lab demonstrated that rodents with ad libitum access to a sugar solution—mirroring the caloric sugar content of common soft drinks—during the juvenile and adolescent phase exhibit hippocampal-dependent memory impairments later in life. These deficits persist even when the animals stop consuming sugar and resume a healthy diet, underscoring the long-lasting effects of early-life sugar consumption. This trend appears regardless of whether animals consume sugar or artificial sweeteners at young ages; even with intake levels within FDA recommendations, animals show lasting memory impairments as adults.

Memory Deficits Linked To Sugar Consumption May Involve Gut Microbiota Alterations Affecting Cognitive Function

Kanoski notes potential mechanisms behind these deficits, pointing out evidence of significant changes in the gut microbiome following high-sugar diets during development. These microbial shifts may alter cognitive function, suggesting that the gut-brain axis plays a role in sugar-induced memory impairments.

Processed Foods Impair Memory Through Glycation End Products

Junk Food Diet Causes Lasting Memory Impairments, Difficult to Reverse Even After Switching To Healthy Diet

In another model, rodents consuming a “total junk food diet”—composed of items like chocolate peanut butter cups, potato chips, and high-fat, high-sugar chow—develop developmental window-specific memory impairments. These effects are especially pronounced if the unhealthy diet is introduced during key developmental stages and prove difficult to reverse even when switching to a healthy diet later. However, exercise in adulthood has been shown in some rodent studies to partially rescue these deficits.

High-Temperature Cooking of Healthy Foods Induces Ages, Impairing Memory Development

Kanoski’s team also investigates the role of food processing itself. By baking otherwise healthy chow at high temperatures, they induce the Maillard reaction, which creates advanced glycation end products (AGEs). AGEs are normally present in small amounts in the body and are associated with aging, diabetes, and cellular damage. When animals consume AGE-enriched diets during development, they show clear memory impairments as adults, suggesting that even healthy foods can lose their cognitive benefits if overly processed or cooked at high temperatures.

Macronutrient Ratios and Micronutrient Deficiency Affect Cognitive Function

Studies Link Excess Sugar and Saturated Fat Intake To Impaired Hippocampal-Dependent Memory

Human studies corroborate findings from rodent research. Work by Dick Stevenson and others shows that, even among healthy young adults, habitual diets high in sugar and saturated fats are linked to poorer performance on hippocampal-dependent memory tasks. Both Kanoski and Huberman agree that excess sugar and saturated fats should be avoided for optimal memory function.

Healthy Rodent Research Diet Limits Nutrient Enhancement Studies, Focusing On Deficits

Kanoski explains that standard laboratory rodent diets are exceptionally healthy, with balanced macronutrients and complex carbohydrates. This makes it easier to detect negative dietary effects rather than improvements, as ...

The gut-brain axis is increasingly recognized as a sophisticated system through which gut-derived signals—neural, microbial, and hormonal—influence brain function and memory. Multiple converging lines of research highlight the interplay between vagal signaling, microbiota, metabolic hormones, and their combined impact on hippocampal-dependent cognition.

Vagus Nerve Communicates Nutrition to Hippocampus

The vagus nerve is traditionally associated with calming the body, but its ascending fibers serve an excitatory purpose, relaying critical signals from the gut to the brain. Mechanoreceptors in the stomach monitor distension while chemoreceptors in the intestines sense nutrients, resulting in a complex “song” of signals rather than a single unified input. These diverse neural cues, transmitted via the vagus through the nodose ganglia to the brainstem, then reach the medial septum and finally the hippocampus, with acetylcholine as the primary neuromodulatory “currency” in this axis.

Vagus Nerve Lesioning Impairs Hippocampal-Dependent Memory via Gut-brain Pathway Disruption

Experimental lesioning of the gastrointestinal-innervating vagus nerve in animals leads to impairments in hippocampal-dependent memory tasks. Furthermore, vagal nerve stimulation (VNS) linked to natural feeding cues can rescue diet-induced memory impairments. Ongoing research explores whether VNS may ameliorate early Alzheimer’s pathology. The integrity of the vagal pathway is thus essential for optimal memory function.

Taiwanese Data Links 1980s Truncal Vagotomy For Ulcers to Increased Dementia Risk

Supporting data from Taiwan reveals that patients who underwent truncal vagotomy for ulcers in the 1980s-1990s show a higher probability of developing dementia later in life. This correlation implicates disrupted vagal signaling as a long-term risk factor for neurodegeneration. Ongoing registry analyses aim to further clarify these risks in different populations.

Acetylcholine in Hippocampus During Eating Encodes Context and Promotes Memory

Acetylcholine release in the hippocampus is dynamically modulated by eating. Using fiber photometry, studies reveal a “staircase” pattern: acetylcholine ramps up during eating, dips during pauses, and ends at a higher baseline post-meal. This postprandial acetylcholine elevation is thought to encode contextual memory of the meal, enabling animals to recall where and what they ate for future foraging success.

Taste and Post-Oral Nutrient Sensing Drive Vagal-Acetylcholine-Memory Signal

Post-ingestive nutrient sensing—not taste alone—is necessary for this gut-brain-memory pathway. Non-nutritive sweeteners like stevia, despite providing sweet taste, do not trigger hippocampal acetylcholine release in animal models. Instead, a combination of taste and nutrient detection after ingestion is essential to drive vagal signals that ultimately release acetylcholine in the hippocampus, indicating an integrated detection system that links sensory and metabolic cues for memory encoding.

Hormones Independently Signal Metabolic Status To Memory Systems

Beyond neural routes, the hippocampus hosts receptors for key metabolic hormones such as [restricted term], ghrelin, and leptin. These hormones deliver humoral signals about the body's energy status, providing a parallel input to the hippocampus alongside neural vagal signals. The hippocampus integrates these multisensory cues—neural and hormonal—to comprehensively monitor nutritional state and adapt memory processes accordingly.

Bacterial Populations Correlate Wit ...

Scott Kanoski discusses how food reward mechanisms in the brain are dynamic, deeply state-dependent, and shaped by physiological, psychological, and social influences—highlighting both specific neural circuits such as the mesolimbic [restricted term] pathway and the plasticity of food preferences.

Mesolimbic [restricted term] Pathway Responds To Food Reward Based On State

The mesolimbic [restricted term] system serves as a neural currency for multiple rewards, including both palatable foods and substances of abuse. Kanoski notes that there is considerable overlap in the brain between substance abuse and food consumption, but this does not mean food addiction is identical to drug addiction.

Palatable Foods Activate [restricted term] Release, but Bland Foods Can Do So When an Animal Is Food-Restricted or Nutrient-Deprived

Typically, palatable foods like sweets or high-fat items activate [restricted term] release. However, in food-restricted or nutrient-deprived states, even bland foods trigger pronounced [restricted term] signaling, demonstrating that the system is modulated by physiological need and relevance.

Mesolimbic [restricted term]: A Neural Currency For Rewards, State and Relevance Dependent

Thus, the mesolimbic [restricted term] system flexibly tracks the reward value of foods based on the animal’s current state, emphasizing that food rewards are not fixed but highly context-dependent.

Food Preferences: Plastic and Rewirable Through Choices

The food reward system is malleable: with changing eating patterns or experience, preferences and neural responses shift.

Sugar Reduction Alters Sweetness Perception Through Reward System Plasticity

Research shows that reducing sugar intake can change how sweetness is perceived, reflecting reward system plasticity. The effect is underpinned by changes in [restricted term] signaling that calibrate the perceived intensity or desirability of sweet foods as experience changes.

[restricted term] Release to Sucrose Eliminated After Learning Sucrose Predicts Illness, Showing Food Reward Circuitry Malleability

A dramatic example of plasticity in the food reward system is conditioned taste aversion. If an animal learns that sucrose consumption predicts malaise—such as after pairing sucrose with an illness-inducing compound—[restricted term] release in response to sucrose consumption disappears. This demonstrates that learned associations can profoundly rewire the neural response to foods once considered rewarding.

The Distinction Between Hunger Suppression and Craving Reduction

Appetite suppression and reduction in food cravings involve different neural mechanisms, and interventions may have distinct effects depending on which system they target.

Appetite Suppression by Glp-1 Drugs Involves Vagal and Brainstem Mechanisms, While Reducing Cravings May Require Engaging Higher-Order Brain Regions Like the Prefrontal Cortex and Hippocampus, Potentially Limited by Blood-Brain Barrier Penetration

Kanoski discusses drugs like GLP-1 agonists that reduce appetite. These appear to work primarily through increased meal satiation via the gut-vagus-brainstem pathway. Whether these drugs affect higher-order brain regions such as the prefrontal cortex or hippocampus—areas involved in cognition, memory, and perhaps controlling food-related thoughts or “food noise”—remains unclear due to questions about blood-brain barrier penetration ...